Jefferies lowered the firm’s price target on Cadre (CDRE) to $45 from $55 and keeps a Buy rating on the shares. The firm says the company missed its Q4 earnings estimate by 36% with Cadre’s nuclear safety revenue dropping 7% in fiscal 2025. The 13% pullback in the shares creates a buying opportunity, the analyst tells investors in a research note. Jefferies believes Cadre’s core story remains intact.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDRE:
